Amir Sarayani, Pharm.D., M.P.H.

Amir Sarayani

Contact Information:


Curriculum Vitae


  • Doctor of Pharmacy (Pharm.D.), Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
  • Master of Public Health, School of Public Health, Tehran University of Medical Sciences (TUMS), Tehran, Iran

Entry Date into the POP Ph.D. program:  Spring, 2017

Research Interests

  •  Pharmacoepidemiology
  •  Comparative Safety and Effectiveness Research
  •  Pharmaceutical Policy Evaluation

Professional Experience

  • Graduate Assistant, University of Florida College of Pharmacy (2017 – present)
  • Pharmacy Manager, Institutional Pharmacies, Tehran University of Medical Sciences (2014-2016)
  • Research Associate, Research Center for Rational Use of Drugs, Tehran University of Medical Sciences (2011-2016)
  • Consultant Pharmacist, Drug and Poison Information Center, Tehran University of Medical Sciences (2009-2011)


  • 2nd Best Student Abstract, 35th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, 2019
  • Graduate School Fellowship, University of Florida, 2017
  • Best Reviewer, Pharmacoepidemiology and Drug Safety Online Journal, 2013 
  • Award-Winning Poster, 2nd GlobalSymposium on Health Systems Research-China, 2012


  • Sarayani A, Albogami Y, Elkhider M, Hincapie-Castillo JM, Brumback BA, Winterstein AG. Comparative effectiveness of risk mitigation strategies toprevent fetal exposure to mycophenolate. BMJ Quality & Safety (2019) – ahead of print (DOI: 10.1136/bmjqs-2019-010098).
  • Wei YJ, Chen C,Sarayani A, Winterstein AG. Performance of the Centers for Medicare & Medicaid Services’ opioid overutilization criteria for classifying opioid usedisorder or overdose. JAMA. 2019;321:609–611
  • Pham PN, Xiao H, Sarayani A, Chen M, Brown JD. Risk factors associated with 7-versus 30-dayreadmission among patients with heart failure using the nationwide readmission database. Medical Care. 2019;57:1-7 4
  • Ebrahimpour S, Nosrati M,Mohammadi M, Kamyab H, Sarayani A, Mahmoodzadeh H, et al. Impact of protocol implementation on rationalization of albumin use in a tertiary careteaching hospital in Tehran, Iran. Journal of Research in Pharmacy Practice. 2018;7:182
  • Sarayani A, Mashayekhi M, Nosrati M, Jahangard-RafsanjaniZ, Javadi M, Saadat N, et al. Efficacy of a telephone-based intervention among patients with type-2 diabetes; a randomized controlled trial in pharmacypractice. International Journal of Clinical Pharmacy. 2018;40:345-35